Sign In
Buy SRRA
$54.99
+0 (+0%)
At Close: Oct 03, 2022
GSK Receives Regulatory Nod for Consumer Healthcare Demerger
01:17pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
GSK progresses with the separation of its Consumer Healthcare business from biopharmaceuticals into a separate public company, Haleon, as it gets regulatory approval from the FCA.
GSK Receives Regulatory Nod for Consumer Healthcare Demerger
10:33am, Thursday, 02'nd Jun 2022
GSK progresses with the separation of its Consumer Healthcare business from biopharmaceuticals into a separate public company, Haleon, as it gets regulatory approval from the FCA.
Was This Acquisition a Smart Move for GlaxoSmithKline?
02:00pm, Saturday, 14'th May 2022 The Motley Fool
The British drugmaker recently announced that it agreed to acquire a late-stage biopharmaceutical company.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sierra Oncol
SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA
04:57pm, Monday, 02'nd May 2022
CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Sierra Oncology, Inc (NasdaqGM: SRRA) to GlaxoSmithKline plc (NYSE: GSK). Under the terms of the proposed tra
Biotech Stock Roundup: SRRA Surges on GSK Buyout, HALO Offers Update & More
05:34pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Acquisition news from GlaxoSmithKline (GSK) and HALO are a few key highlights from the biotech sector during the past week.
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
02:03pm, Thursday, 14'th Apr 2022 Benzinga
Upgrades
For United Parcel Service Inc (NYSE:UPS), Loop Capital upgraded the previous rating of Hold to Buy. For the fourth quarter, United Parcel Service had an EPS of $3.59, compared to year-ago qua
Best Biotech Stocks To Buy Now? 5 To Know
01:50pm, Thursday, 14'th Apr 2022
Check out these biotech stocks with exciting developments today.
Analyst Ratings for Sierra Oncology
01:15pm, Thursday, 14'th Apr 2022 Benzinga
Sierra Oncology (NASDAQ:SRRA) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
3
0
0
Last
SHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc.
03:15pm, Wednesday, 13'th Apr 2022
NEW YORK , April 13, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sierra Oncology, Inc. ("Sierra" or t
Glaxo (GSK) to Buy Sierra for $1.9B, Add Hematology Drug
02:18pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
The acquisition of Sierra Oncology (SRRA) will add late-stage oncology pipeline candidate, momelotinib to Glaxo's (GSK) hematology pipeline.
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
02:01pm, Wednesday, 13'th Apr 2022 Benzinga
Upgrades
According to Oppenheimer, the prior rating for Apollo Global Management Inc (NYSE:APO) was changed from Perform to Outperform. In the fourth quarter, Apollo Global Management showed an EPS of
Late-Stage Biopharmaceutical Sierra Oncology announces acquisition by GSK
01:49pm, Wednesday, 13'th Apr 2022
Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share in cash. That represents a total equity value of $1
Why Sierra Oncology Stock Is Soaring Today
12:14pm, Wednesday, 13'th Apr 2022 The Motley Fool
GlaxoSmithKline is adding another cancer asset to its portfolio by acquiring U.S.-based Sierra Oncology.
Why Is Sierra Oncology (SRRA) Stock Up Today?
11:42am, Wednesday, 13'th Apr 2022
Late-phase cancer treatment company Sierra Oncology is up big today after being acquired by GlaxoSmithKline. SRRA stock is soaring.
